CD8A and invasive ductal breast carcinoma: Similarly, Rathore et al. have shown CD3+, CD4+, and CD8+ intratumoral and stromal TILs to predict favorable survival outcomes in infiltrating ductal carcinoma, where patients with intratumoral CD4+ and stromal CD8+ cells showed the highest survival [36].